Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ofri Doppelt-Flikshtain"'
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Medication-related osteonecrosis of the jaw is a serious complication that develops in oncologic patients treated with Zoledronic acid. Although used for over 30 years, the influence of Zoledronic acid on bone has been thoroughly investig
Externí odkaz:
https://doaj.org/article/e3dec52068c64b4d80fd96e190e7502c
Autor:
Ofri Doppelt-Flikshtain, Amin Younis, Tal Tamari, Ofir Ginesin, Talia Shentzer-Kutiel, David Nikomarov, Gil Bar-Sela, Benjamin R. Coyac, Yehuda G. Assaraf, Hadar Zigdon-Giladi
Publikováno v:
Cancers; Volume 15; Issue 6; Pages: 1818
Background: Osteosarcoma (OS) mortality is attributed to lung metastases. Endothelial progenitor cells (EPCs) mediate the angiogenic switch in several cancers. The spatial proximity between EPCs and OS in the bone led to the hypothesis that EPCs-oste
Autor:
Gal Chen, Rotem Levin, Shira Landau, Maya Kaduri, Omer Adir, Iris Ianovici, Nitzan Krinsky, Ofri Doppelt-Flikshtain, Jeny Shklover, Janna Shainsky-Roitman, Shulamit Levenberg, Avi Schroeder
Publikováno v:
Proceedings of the National Academy of Sciences. 119
Progress in bottom-up synthetic biology has stimulated the development of synthetic cells (SCs), autonomous protein-manufacturing particles, as dynamic biomimetics for replacing diseased natural cells and addressing medical needs. Here, we report tha
Autor:
Sivan Arber Raviv, Mohammed Alyan, Egor Egorov, Agam Zano, Moshit Yaskin Harush, Calvin Pieters, Hila Korach-Rechtman, Adi Saadya, Galoz Kaneti, Igor Nudelman, Shai Farkash, Ofri Doppelt Flikshtain, Lucy N. Mekies, Lilach Koren, Yoav Gal, Ella Dor, Janna Shainsky, Jeny Shklover, Yochai Adir, Avi Schroeder
Publikováno v:
Journal of Controlled Release
Acute Respiratory Distress Syndrome (ARDS), associated with Covid-19 infections, is characterized by diffuse lung damage, inflammation and alveolar collapse that impairs gas exchange, leading to hypoxemia and patient' mortality rates above 40%. Here,
Autor:
Netanel Korin, Jeny Shklover, Boaz Mizrahi, Arbel Artzy-Schnirman, Josué Sznitman, Avi Schroeder, Ofri Doppelt Flikshtain, Sivan Arber Raviv, Adi Gross
Publikováno v:
Adv Drug Deliv Rev
Over the past years, advanced in vitro pulmonary platforms have witnessed exciting developments that are pushing beyond traditional preclinical cell culture methods. Here, we discuss ongoing efforts in bridging the gap between in vivo and in vitro in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81fec99e7b83e640d4223819254b41bb
https://europepmc.org/articles/PMC7611797/
https://europepmc.org/articles/PMC7611797/